- Home
- DAWN vs FSUN Comparison
DAWN vs FSUN Comparison
Compare DAWN & FSUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- FSUN
- Stock Information
- Founded
- DAWN 2018
- FSUN 1892
- Country
- DAWN United States
- FSUN United States
- Employees
- DAWN N/A
- FSUN N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- FSUN Major Banks
- Sector
- DAWN Health Care
- FSUN Finance
- Exchange
- DAWN Nasdaq
- FSUN Nasdaq
- Market Cap
- DAWN 1.3B
- FSUN 1.1B
- IPO Year
- DAWN 2021
- FSUN N/A
- Fundamental
- Price
- DAWN $12.79
- FSUN $40.03
- Analyst Decision
- DAWN Strong Buy
- FSUN Hold
- Analyst Count
- DAWN 7
- FSUN 1
- Target Price
- DAWN $36.17
- FSUN N/A
- AVG Volume (30 Days)
- DAWN 1.0M
- FSUN 99.2K
- Earning Date
- DAWN 10-30-2024
- FSUN 01-01-0001
- Dividend Yield
- DAWN N/A
- FSUN N/A
- EPS Growth
- DAWN N/A
- FSUN N/A
- EPS
- DAWN N/A
- FSUN 3.05
- Revenue
- DAWN $101,953,000.00
- FSUN $348,035,000.00
- Revenue This Year
- DAWN N/A
- FSUN N/A
- Revenue Next Year
- DAWN $36.10
- FSUN $80.04
- P/E Ratio
- DAWN N/A
- FSUN $13.11
- Revenue Growth
- DAWN N/A
- FSUN N/A
- 52 Week Low
- DAWN $11.94
- FSUN $33.00
- 52 Week High
- DAWN $18.07
- FSUN $44.37
- Technical
- Relative Strength Index (RSI)
- DAWN 39.97
- FSUN 52.59
- Support Level
- DAWN $12.26
- FSUN $37.15
- Resistance Level
- DAWN $12.81
- FSUN $40.80
- Average True Range (ATR)
- DAWN 0.52
- FSUN 2.53
- MACD
- DAWN -0.05
- FSUN -0.22
- Stochastic Oscillator
- DAWN 28.94
- FSUN 40.22
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About FSUN FirstSun Capital Bancorp
Firstsun Capital Bancorp is the financial holding company for Sunflower Bank, National Association. It provides a full range of deposit, lending, treasury management, wealth management and online banking products and services. The company operates in two segments - Banking operations and Mortgage operations, out of which the majority of the revenue is generated from the Banking operations segment.